The XEOMIN Difference

Convenience and value for XEOMIN in your practice and your patients

XEOMIN does not require refrigeration prior to reconstitution1

  • Can be shipped and stored at room temperature
  • Unopened vials can be stored at room temperature for up to 36 months
  • Offers flexible storage options:
    • Room temperature: 20°C to 25°C (68°F to 77°F)
    • Refrigerated: 2°C to 8°C (36°F to 46°F)
    • In freezer: -20°C to -10°C (-4°F to 14°F)

XEOMIN is packaged to minimize waste2

  • Available in 50-unit, 100-unit, and 200-unit single-dose vials1
    • Multiple vial options may reduce dosing waste and save patients out-of-pocket costs
  • XEOMIN reduces use and disposal of packaging material

XEOMIN offers potential savings*

  • Same price per toxin unit for the 50-, 100-, and 200-unit vials

hcp_1.1_Potential Savings Table

*Xeomin’s list price of $466/100U vial and $932/200U vial compared to representative product with list (WAC) price of $579/100U vial and $1,158/200U vial. Source of product price: Medi-Span Price RX, January 1, 2016. Prices subject to change.

**Hypothetical annual cost savings utilizing XEOMIN list (WAC) price and representative product list (WAC) price. The price listings for XEOMIN and the representative product are for therapeutic class acquisition cost purposes only and are not reflective of any assumption of equivalence regarding the indications, efficacy, safety profiles, or dosing regimens of the listed products. Referenced prices do not take into account any discounts, rebates, or other price incentives and do not necessarily reflect actual prices paid by purchasers or consumers.

The potency units of XEOMIN are specific to the preparation and assay method used and are not interchangeable with other preparations of botulinum toxin products. Therefore, Units of biological activity of XEOMIN cannot be compared to or converted into Units of any other botulinum toxin products.


  1. XEOMIN® [package insert]. Raleigh, NC: Merz North America, Inc; 2015.
  2. Thistle F. Greenhouse gas emissions and botulinum neurotoxin packaging. Hosp Pharm Eur. 2012:64.